FibroCalc
FibroCalc and Acticalc estimate both fibrosis and necroinflammatory activity with a blood sample done at a local laboratory. Same highly significant performance for both advanced fibrosis and cirrhosis regardless of ethnicity, HBeAg status, HCV genotype, viral load, gender or ALT transaminase level.
- ActiCalc is more accurate than ALT transaminases for the diagnosis of necroinflammatory activity.
- FibroCalc is as performant in the diagnosis of early stages of fibrosis as it is in more advanced stages , from no fibrosis to cirrhosis.
- best applicability among all non-invasive methods (98%).